Yanjun Yi

No. 180 Fenglin Road
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.

MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.

Journal: Respiratory research

Published: October 11, 2025

Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy.

Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy.

Journal: Science advances

Published: September 12, 2025

Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

Journal: Cell death & disease

Published: August 25, 2025

Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma.

Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma.

Journal: Cancer letters

Published: August 01, 2025

Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung Adenocarcinoma.

Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung Adenocarcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 08, 2025

ZNF146 accelerates lung adenocarcinoma progression through MDM2/p53 and PHGDH/ferroptosis.

ZNF146 accelerates lung adenocarcinoma progression through MDM2/p53 and PHGDH/ferroptosis.

Journal: Cell & bioscience

Published: February 24, 2025

Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Journal: Nature communications

Published: January 31, 2025

Lactylation and regulated cell death.

Lactylation and regulated cell death.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: November 27, 2024

Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma.

Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma.

Journal: Thoracic cancer

Published: August 28, 2024

MiR-23b-3p Improves Brain Damage after Status Epilepticus by Reducing the Formation of Pathological High-Frequency Oscillations via Inhibition of cx43 in Rat Hippocampus.

MiR-23b-3p Improves Brain Damage after Status Epilepticus by Reducing the Formation of Pathological High-Frequency Oscillations via Inhibition of cx43 in Rat Hippocampus.

Journal: ACS chemical neuroscience

Published: July 05, 2024

Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential.

Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential.

Journal: International immunopharmacology

Published: February 01, 2024

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 29, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026